Plastic Surgery Practice
  • Client Objectives
    • Aesthetics
    • Dermatology
    • Rejuvenation
  • Practice Management
    • Marketing
    • Office Management
    • Technology
  • Treatment Solutions
    • Innovations
    • Products
    • Pharmaceuticals
  • Resources
    • Podcasts
    • Videos
    • Webinars
    • White Papers

Select Page

Tag: revance therapeutics

All

Popular
Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

Revance Reports Q4 and Full Year 2021 Financial Results; Credits Dermal Filler Sales for Growth

The company also announced progress on its DaxibotulinumtoxinA for Injection for glabellar lines and intent to launch the RHA Redensity dermal filler in the second half of 2022.

  • Revance Resubmits BLA to FDA for DaxibotulinumtoxinA for Injection

  • Revance Closes on $300M Note Purchase Agreement with Athyrium Capital Management

  • FDA Accepts Revance Resubmission for Frown Line Treatment

  • FDA Approves Revance Daxxify for Frown Lines

  • Studies Show Efficacy of Daxxify to Treat Frown Lines

  • Revance Publishes 2 Papers on Daxxify Injectable

  • Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio

All

Latest
Sorry, No Posts Found

All

Latest
Botulinum Toxin May Help Improve the Appearance of New Scars

Botulinum Toxin May Help Improve the Appearance of New Scars

Botulinum toxin type A may improve the aesthetic outcome of new scars in patients prone to abnormal scarring.

  • Study Shows Improved Vitiligo Outcomes with Combined Antioxidant and Light Therapy

    Study Shows Improved Vitiligo Outcomes with Combined Antioxidant and Light Therapy

  • European Regulators Recommend First Potential Systemic Treatment for Vitiligo

    European Regulators Recommend First Potential Systemic Treatment for Vitiligo

  • Skin Barrier Changes Precede Visible Signs of Flap Necrosis, Study Finds

    Skin Barrier Changes Precede Visible Signs of Flap Necrosis, Study Finds

Sorry, No Posts Found

Plastic Surgery Practice

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved